Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

424344454647484950

TOP NEWS: AstraZeneca wins EU recommendation for breast cancer drugs

27th Jun 2022 09:04

(Alliance News) - AstraZeneca PLC said on Monday that its breast cancer treatments, Lynparza and Enhertu, have been recommended for approval in the EU. Read More

LONDON MARKET PRE-OPEN: AstraZeneca breast cancer drugs recommended

27th Jun 2022 07:58

(Alliance News) - Stock prices in London are seen opening higher on Monday following a strong close in the US on Friday and a rally across Asian markets, amid gatherings of world leaders and central bankers at separate meetings in Europe this week. Read More

AstraZeneca's Wilson disease treatment shows promise in phase 3 trials

23rd Jun 2022 15:59

(Alliance News) - AstraZeneca PLC on Thursday reported strong results from phase III clinical trials for ALXN1840. Read More

Merck & Co, Astra drug improves survival in prostate cancer sufferers

21st Jun 2022 22:01

(Alliance News) - Merck & Co Inc on Tuesday said its Lynparza drug, developed alongside AstraZeneca PLC, improved survival rates for some sufferers of prostate cancer. Read More

AstraZeneca's polyneuropathy candidate Eplontersen sees positive data

21st Jun 2022 08:32

(Alliance News) - AstraZeneca PLC on Tuesday said eplontersen, its candidate for a form of hereditary polyneuropathy, demonstrated significant positive results in a phase 3 trial interim analysis. Read More

LONDON MARKET MIDDAY: Rebound stumbles as US Fed hike jitters grow

14th Jun 2022 12:02

(Alliance News) - Tuesday's dead cat bounce didn't live past the morning in Europe, with the FTSE 100 back in the red at midday as investors fret over an upcoming US interest rate decision. Read More

LONDON BROKER RATINGS: Berenberg and HSBC upgrade Wizz Air

14th Jun 2022 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday: Read More

LONDON BRIEFING: BoE dilemma as basic UK pay falls 2.2% in real terms

14th Jun 2022 08:17

(Alliance News) - Average pay in the UK is failing to keep up with rampant inflation, though the country's jobless rate remains at nearly a 50-year low, posing a conundrum for the Bank of England when it meets this week. Read More

Daiichi Sankyo doses first person in breast cancer treatment trial

13th Jun 2022 13:52

(Alliance News) - Daiichi Sankyo Co Ltd on Monday said it dosed the first patient in the Tropion-Breast02 phase three trial, evaluating the safety and efficacy of datopotamab deruxtecan in patients with breast cancer. Read More

AstraZeneca's Calquence shows longer survival rate for leukaemia form

9th Jun 2022 10:34

(Alliance News) - AstraZeneca PLC on Thursday said Calquence, when used in combination with obinutuzumab, showed a longer-term survival rate in people with a form of leukaemia. Read More

AstraZeneca antibody reduces risk of severe Covid-19 or death

8th Jun 2022 09:48

(Alliance News) - AstraZeneca PLC on Wednesday said its Evusheld antibody reduces the risk of serious Covid-19 symptoms or death from the virus in vulnerable sufferers. Read More

LONDON MARKET CLOSE: FTSE 100 rallies 1%; pound up ahead of UK PM vote

6th Jun 2022 17:02

(Alliance News) - Equities in London had a buoyant start to the week after a four-day break, with oil majors and miners leading the gainers amid optimism over easing Covid rules in China. Read More

LONDON MARKET MIDDAY: Pound unfazed as UK PM faces no-confidence vote

6th Jun 2022 12:21

(Alliance News) - Stock prices in London were higher at midday on Monday following the long holiday weekend in the UK, after an easing of virus lockdowns in China, while the pound appreciated ahead of a no-confidence vote in Westminster. Read More

AstraZeneca sees breast cancer drug Enhertu improve median overall survival

6th Jun 2022 09:57

(Alliance News) - AstraZeneca PLC on Saturday said its jointly developed breast cancer drug Enhertu showed improved overall survival in a phase III trial, while its leukaemia treatment Calquence showed a sustained survival benefit in another phase III trial. Read More

TOP NEWS: AstraZeneca Covid vaccine wins booster jab approval in EU

23rd May 2022 08:58

(Alliance News) - AstraZeneca PLC on Monday announced its Covid-19 vaccine Vaxzevria has received approval from the EU to be used as a third-dose booster jab. Read More

REPEAT: LONDON BRIEFING: Kingfisher plans capital return

23rd May 2022 08:24

(Alliance News) - Kingfisher on Monday said first-quarter sales were above pre-pandemic levels but had weakened year-on-year. The owner of the B&Q chain of DIY stores also unveiled a GBP300 million share buyback. Read More

LONDON BRIEFING: Kingfisher plans capital return despite cost pressure

23rd May 2022 08:18

(Alliance News) - Kingfisher on Monday said first-quarter sales were above pre-pandemic levels but had weakened year-on-year. The owner of the B&Q chain of DIY stores also unveiled a GBP300 million share buyback. Read More

LONDON MARKET MIDDAY: High inflation in UK and EU leaves stocks flat

18th May 2022 12:18

(Alliance News) - Europe's blue-chip stock benchmarks were drifting aimlessly at midday on Wednesday, as markets seemed unsure how to react to hot inflation figures in the UK and the eurozone. Read More

LONDON BROKER RATINGS: Kepler cuts Astra to hold; RBC raises Reckitt

18th May 2022 10:34

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday afternoon: Read More

TOP NEWS: AstraZeneca wins license to make and sell Covid antibodies

17th May 2022 09:12

(Alliance News) - AstraZeneca PLC on Tuesday said it signed a license agreement with RQ Biotechnology Ltd to develop, manufacture and sell Covid antibodies worldwide. Read More

424344454647484950
FTSE 100 Latest
Value10,600.53
Change-2.95